WeightWatchers (Sequence) vs Willow: Which GLP-1 Provider Is Better?

By Iacob Pastina, Independent Researcher & Publisher

Reviewed & updated August 14, 2026 · Cites primary sources (FDA, NEJM, CMS) · Not medical advice

54 providers verified independently·Independent research·How we rank →

Short answer: Willow scores higher on our rubric, 7.5/10 against 7.4/10. Full reasoning, pricing and the cases where the other one wins are below.

Visit Embody - our featured pick →or find your match

Willow beats WeightWatchers (Sequence) overall, scoring 7.5/10 vs 7.4/10. Published pricing is not a like-for-like monthly comparison: WeightWatchers (Sequence) is $74/mo membership + medication; Willow is from $299/mo. Choose WeightWatchers (Sequence) for users who want glp-1 medication combined with the weightwatchers program and community, on the $74/mo med+ membership ($20/mo for the first 3 months), with glp-1 meds billed separately. Choose Willow for users who want comprehensive clinical support with flexibility between injectable and oral compounded semaglutide routes.

A side-by-side look at WeightWatchers (Sequence) and Willow to help you decide. We compare them on:

•Starting price per month
•Our overall score, out of 10
•Medication type, brand-name or compounded
•Whether they accept insurance
•Who each one is best for

WeightWatchers (Sequence)

#24 of 54

7.4/10

WeightWatchers' clinical weight management arm (acquired from Sequence). The MED+ membership is $20/mo for the first 3 months, then $74/mo ongoing. Medication is billed separately: the current self-pay path lists $199/mo for the first two fills, then $349/mo ongoing. The lineup includes Saxenda, Wegovy, Zepbound, and compounded semaglutide/tirzepatide.

Visit WeightWatchers (Sequence)

Higher Rated

Willow

#20 of 54

7.5/10

Personalized GLP-1 weight loss with ongoing clinical support. Compounded semaglutide and tirzepatide only, Willow explicitly does not prescribe brand-name Wegovy or Zepbound. Added oral compounded semaglutide tablets as a non-injectable option.

Visit Willow

Feature	WeightWatchers (Sequence)	Willow
Why each one	The only GLP-1 program backed by decades of structured weight loss methodology, combining medication with WW's points system, community workshops, and behavioral tools.	One of the few compounded-only platforms offering both injectable and daily oral semaglutide tablets, useful for users who want a non-injectable option without leaving the GLP-1 compounded category.
Our Score	7.4/10	7.5/10
Headline Price	$74/mo membership + medication	from $299/mo
Medication Type	Both	Compounded
Insurance Accepted	Yes	No
Best For	Users who want GLP-1 medication combined with the WeightWatchers program and community, on the $74/mo MED+ membership ($20/mo for the first 3 months), with GLP-1 meds billed separately	Users who want comprehensive clinical support with flexibility between injectable and oral compounded semaglutide routes
Watch out for	The $74/mo ongoing membership excludes medication; the self-pay medication path is advertised at $199 for the first two fills, then $349/mo	Compounded-only, no brand-name Wegovy or Zepbound through the platform
Ranking	#24	#20
Get started	Visit WeightWatchers (Sequence)	Visit Willow

Pros & Cons Compared

WeightWatchers (Sequence)

Pros

+Combines GLP-1 medication with WeightWatchers' proven points system and community support
+Insurance accepted for medication, can reduce costs significantly with qualifying plans
+Decades of brand trust and weight loss expertise applied to clinical medication management
+Access to WW community, workshops, and digital tools alongside medication

Cons

−The $74/mo ongoing membership excludes medication; the self-pay medication path is advertised at $199 for the first two fills, then $349/mo
−The WW program integration adds complexity that medication-only users won't value
−The Sequence acquisition is still integrating, some operational inconsistencies remain
−Less medication flexibility than pure-play GLP-1 platforms

Willow

Pros

+Includes monthly provider check-ins and dose adjustments at no extra cost
+Offers both injectable AND oral compounded semaglutide, one of few platforms with a daily oral tablet option
+$299/mo all-in for compounded semaglutide with monthly provider support
+90%+ patient retention rate after 3 months per their published outcomes data

Cons

−Compounded-only, no brand-name Wegovy or Zepbound through the platform
−Tirzepatide pricing reaches $499-$524 at higher doses, starting dose is $399/mo
−Cash-pay only, no insurance billing, though they provide superbills for FSA/HSA
−Founded in 2024, less track record than Ro or Hims, though growth has been fast

Our Verdict

Willow edges out WeightWatchers (Sequence) with a score of 7.5/10 vs 7.4/10. Published pricing is not a like-for-like monthly comparison: WeightWatchers (Sequence) is $74/mo membership + medication; Willow is from $299/mo. WeightWatchers (Sequence) accepts insurance, which can significantly reduce your out-of-pocket costs. WeightWatchers (Sequence) offers both brand-name and compounded medications, giving you more flexibility.